(median age 73 years [interquartile range [61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80], onset-totPA time 129 min ). Among 24 patients (21%) with extensive hypoattenuation on CTASI and extensive thrombus burden (combined score ^ 10), only 4% (1/24) were functionally independent whereas mortality was 50% (12/24). In contrast, 57% (51/90) of patients with less affected scores (combined score 11-20) were functionally independent and mortality was 10% (9/90; p ! 0.001). Parenchymal hematoma rates were 30% (7/23) vs. 8% (7/88), respectively (p = 0.008). Conclusion: CTA identifies a large hyperacute stroke population with high mortality and low likelihood for independent functional outcome despite early thrombolysis.
Introduction
Some stroke patients will have a poor functional outcome despite early intravenous (IV) thrombolysis with alteplase (rtPA) [1] . A magnetic resonance imaging (MRI)-based malignant profile of early brain ischemia has been demonstrated in the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study and the Echoplanar Imaging Thrombo-lytic Evaluation Trial (EPITHET) [2, 3] . Patients with a malignant profile, characterized by a large lesion volume on diffusion-weighted imaging (DWI) and/or perfusion imaging (PI), had a low chance (17 and 18%, respectively) for an independent functional outcome if thrombolyzed within 3-6 h from symptom onset.
Compared with MRI, non-contrast CT (NCCT) is more widely available in local general hospitals where most stroke patients present [4] . Quantification of early ischemic changes on the pre-treatment NCCT identifies patients who are unlikely to achieve an independent functional outcome despite thrombolysis within 3 h from onset [1] . However, the percentage of patients who have extensive early ischemic changes in NCCT is low and their functional outcomes are variable [1, [5] [6] [7] .
CT angiography (CTA) is increasingly performed in the emergency department and can reliably determine intracranial vascular status [8] . More proximal intracranial arterial occlusions are associated with low recanalization rates, likely due to larger thrombus burden [9] [10] [11] . Moreover, areas with hypoattenuation on CTA source images (CTASI) may delineate brain tissue with ischemic damage [12, 13] . CT perfusion techniques have also been evaluated in small series of stroke patients receiving IV rtPA [14] .
We sought to determine: (1) the frequency of patients with acute ischemic stroke who have extensive hypoattenuation on CTASI and/or large intracranial thrombus burden on CTA, and (2) whether these patients have a poor functional outcome despite IV thrombolysis within 3 h from symptom onset.
Methods

Patients
We retrospectively studied consecutive (April 2002-September 2007) IV rtPA-treated patients undergoing baseline CTA with a final diagnosis of acute anterior circulation ischemic stroke admitted to Foothills Medical Centre in Calgary. NCCT is the default imaging modality in patients with suspected acute ischemic stroke in our center and followed immediately by CTA prior to IV rtPA treatment. CTA was only sporadically performed at the beginning of the study period evolving to frequent use in IV rtPAtreated patients at the end of the study period. The decision to proceed to CTA is at the discretion of the treating stroke neurologist. For this study we included patients who underwent CTA of the circle of Willis before IV thrombolysis with rtPA within 3 h from symptom onset. We included subjects who underwent additional neurointerventional treatment after IV rtPA treatment in the form of intraarterial (IA) thrombolysis and/or mechanical device use. Exclusion criteria were pre-morbid modified Rankin Scale (mRS) score 1 2 and final diagnosis of posterior circulation stroke. Clinical baseline variables including the National Institute of Health Stroke Scale (NIHSS) score and mRS score are routinely recorded prospectively in the patient record. In cases where these scores were unavailable, they were derived retrospectively [15] .
Functional outcome is recorded prospectively at 3 months in a stroke follow-up clinic. Missing functional outcome data were imputed from the discharge mRS using the last-score-carried-forward principle. Functional independence was defined as mRS scores ^ 2. This study was approved by the local institutional ethics committee.
Imaging
Standard non-helical NCCT was performed on a multislice CT scanner (GE Medical Systems or Siemens) using 120 kV, 170 mAs with 5-mm slice thickness. Coverage was from skull base to vertex with continuous axial slices parallel to the orbitomeatal line. NCCT was followed by CTA with a helical scan technique. Acquisitions were obtained after a single bolus IV contrast injection of 90-120 ml non-ionic contrast media into an antecubital vein at 3-5 ml/s. Imaging was auto-triggered by the appearance of contrast material in the ascending aorta. Minimum coverage was from foramen magnum to centrum semiovale with 0.6-to 1.25-mm slice thickness. Multiplanar volume-reformatted images were immediately created by the CT technologist with 2.5-to 4.0-mm slice thickness in axial, sagittal and coronal planes. This image reformatting was typically completed within minutes and available for review.
Follow-up NCCT was performed routinely and follow-up MRI as indicated by the treating stroke neurologist. Follow-up imaging had to be performed between day 1 and day 7 after symptom onset to be assessed for final infarct extension.
Image Analysis
We prospectively and independently applied the Alberta Stroke Program Early CT Score (ASPECTS) to all baseline NCCT, CTASI and follow-up scans by 3-reader consensus with readers blinded to clinical information and functional outcome. An AS-PECT score of 10 indicates a normal scan, a score of 0 indicates ischemic changes in the complete middle cerebral artery (MCA) territory [5, 16] . On NCCT, early ischemic changes were defined as parenchymal hypoattenuation. On CTASI, regions of relatively diminished contrast enhancement were scored as abnormal [17] . On follow-up NCCT, we applied ASPECTS to regions of subacute brain infarction. On follow-up MRI we similarly scored hyperintense regions on DWI sequences [18] . Hemorrhagic transformation (HT) on follow-up scan was categorized parenchymal hematoma (PH) or hemorrhagic infarction (HI) by ECASS criteria [19] .
Assessment of Thrombus Extent
Intracranial thrombus extent on CTA was assessed with a novel clot burden score (CBS) [20] . CBS allots major intracranial anterior circulation arteries 10 points for contrast opacification on CTA. Two points each are subtracted for occlusive thrombus preventing contrast opacification in the proximal M1, distal M1 or supraclinoid internal carotid artery (ICA) and 1 point each for M2 branches, A1 or infraclinoid ICA. A score of 10 indicates absence of a visible intracranial occlusion on CTA; a score of 0 indicates occlusion of all major intracranial anterior circulation arteries.
Statistical Analysis
Data are reported using standard descriptive statistics. We calculated Spearman's rank correlation coefficient to assess the association of the ASPECTS score on CTASI and the CBS score. We combined the two scores (CTASI-ASPECTS and CBS) to an additive score where 20 is best and 0 is worst. A review of the distribution of the mRS scores according to the combined CTASI-AS-PECTS + CBS score values suggested that combined score values in two categories ( 1 10 and ^ 10) discriminated favorable functional outcome from unfavorable functional outcome and death. We analyzed percentages independent functional outcome (mRS score ^ 2) and fatal outcome at 3 months and PH rates across dichotomized combined CTASI-ASPECTS + CBS score groups ( 1 10 vs. ^ 10). The distribution of outcomes among these groups was compared with the Fisher's exact test. We performed C-statistics to analyze the discriminative ability of baseline imaging scores to predict favorable functional outcome and calculated univariate Spearman's rank correlation coefficients to assess the association of baseline imaging scores with 3-month mRS scores.
Results
Clinical Baseline Characteristics
From a database containing 1,104 consecutive patients who underwent NCCT and CTA for acute cerebrovascular ischemia, 167 patients had a final diagnosis of anterior circulation stroke and received IV thrombolysis with rtPA. Among these, IV thrombolysis was initiated within 3 h from symptom onset and after CTA in 114 patients. These were 62 men with a median (interquartile range 
Imaging Baseline Characteristics
The overall median (IQR) ASPECTS on baseline NCCT was 8 (6-10) and the median (IQR) ASPECTS on baseline CTASI was 7 (5-10). 74 patients (65%) had a demonstrable intracranial arterial occlusion on CTA. The overall distribution of CBS values was right-skewed with a median CBS of 9 (6-10). The CBS showed a moderate positive correlation (Spearman's = 0.65; p ! 0.001) with the ASPECTS on CTASI, however with a large range of CBS scores at a given CTASI-ASPECTS value.
Patients with Extensive Thrombus Burden and/or Extensive Hypoattenuation on CTASI
Twenty-four patients (21%) had extensive hypoattenuation on CTASI and/or extensive thrombus burden with a combined CTASI-ASPECTS + CBS score ^ 10 ( fig. 1 ). Baseline characteristics according to the dichotomized combined score are summarized in table 1 . Patients with a combined score ^ 10 had higher baseline NIHSS scores (p ! 0.001) and were more frequently treated with additional IA therapies (p = 0.018). Further clinical baseline parameters including the onset-to-CTA time were similar between both groups. All individual baseline imaging Patients with a combined score (CS) ^ 10 are very unlikely to achieve an independent functional outcome despite thrombolysis within 3 h from symptom onset (numbers of patients in each group: CS 18-20, n = 42; CS 15-17, n = 26; CS 11-14, n = 22; CS 9-10, n = 12; CS 6-8, n = 7; CS 0-5, n = 5). N CCT = Non-contrast CT; CTASI = CT angiography source images; ASPECTS = Alberta Stroke Program Early CT Score; CBS = clot burden score; NIHSS = National Institute of Health Stroke Scale.
parameters were lower in patients with a combined score ^ 10 compared to patients with a combined score 1 10 (p ! 0.001 for all; table 1 ).
Functional Outcome
At 3 months, 46% (52/114) of patients were functionally independent, 36% (41/114) were functionally dependent and 18% (21/114) were deceased. Figure 2 shows the distribution of functional outcomes according to categorized combined CTASI-ASPECTS + CBS score groups. Of patients with a combined CTASI-ASPECTS + CBS score ^ 10, only 4% (1/24) achieved an independent functional outcome. IV thrombolysis in this patient was started 90 min from symptom onset. In contrast, mortality in this group was 50% (12/24). Of patients with less affected scores (combined CTASI-ASPECTS + CBS score [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , 57% (51/90) were functionally independent and 10% (9/90) were deceased (Fisher's exact test; p ! 0.001).
C-statistics demonstrated additional discriminative ability of the combined CTASI-ASPECTS + CBS score compared to the NCCT-ASPECTS and the CTASI-ASPECTS ( table 2 ) . In parallel, univariate analysis demonstrated a better correlation of the combined CTASI-ASPECTS + CBS score compared to the individual ASPECTS scores with outcome mRS ( table 2 ). The ability of all imaging scores to discriminate independent functional outcome from poor functional outcome was less than the discriminative ability of the baseline NIHSS score ( table 2 ) .
Comparison of Patients with IV Thrombolysis and Combined IV-IA Therapy
Ninety-two patients were treated with IV thrombolysis only and 22 patients received additional IA therapies. Patients who received additional IA therapies were younger, had higher baseline NIHSS scores and more frequently had a combined CTASI-ASPECTS + CBS score ^ 10 ( table 3 ). Among 92 patients treated with IV thrombolysis only, 43 (47%) were functionally independent at 3 months compared to 9 of 22 (41%) patients treated with combined IV-IA therapies (Fisher's exact test, p = 0.64). Among patients with a combined CTASI-ASPECTS + CBS score ^ 10, only 1 of 15 (7%) patients treated with IV thrombolysis and none of 9 (0%) patients who received additional IA therapies achieved an independent functional outcome.
Imaging Outcome
Follow-up images were available for review in 111 patients. The overall median ASPECTS on follow-up images was 7 (4-8). The median ASPECTS on follow-up images was lower among patients with a combined score ^ 10 compared to patients with a combined score 1 10 (2 [0-5] vs. 7 [5] [6] [7] [8] [9] , respectively; p ! 0.001). Overall, 38 of 111 (34%) patients had hemorrhagic transformation on follow-up images with PH in 14 patients (13%) and HI in 24 patients (22%). PH rates were 30% (7/23) among patients with a combined score ^ 10 compared to 8% (7/88) among patients with a combined score 1 10, respectively (Fisher's exact test; p = 0.008). NC CT = Non-contrast CT; CTASI = CT angiography source images; ASPECTS = Alberta Stroke Program Early CT Score; CBS = clot burden score; IV = intravenous; IA = intraarterial.
Discussion
This study demonstrates that rapidly obtainable CT angiographic information combining the extent of hypoattenuation on CTASI and the intracranial thrombus burden on CTA identifies a large (21% of all patients in this study) hyperacute stroke population with a high mortality and very low likelihood for an independent functional outcome despite IV thrombolysis or combined IV-IA therapy initiated within 3 h from symptom onset.
Extensive early ischemic changes on NCCT indicated a low chance of achieving an independent functional outcome in the NINDS rtPA stroke study and the Canadian Alteplase for Stroke Effectiveness Study (CASES) [1, 7] . However, the proportion of patients with extensive early ischemic changes, defined as an ASPECTS of ^ 4, was only 10.9% (66/608 patients) in the NINDS rtPA stroke study and 4.4% (41 of 936 patients) in CASES, respectively [1, 7] . Moreover, functional outcomes of patients with extensive early ischemic changes are variable [7] .
CTASI are more sensitive for detection of infarction and more accurate for predicting the final infarct size and clinical outcome compared with NCCT [17, 21, 22] . Large lesion volumes on CTASI identified patients with MCA occlusion who had a poor functional outcome despite recanalization of the MCA within 6 h from symptom onset [12] . In the same time window (i.e. 6 h from onset), the CTASI lesion volume predicted functional outcome in patients with MCA M1-segment occlusion regardless of the recanalization status in a study by Rosenthal et al. [23] . In our study, the discriminative ability of the combined CTASI-ASPECTS + CBS score to predict independent functional outcome was improved compared to the baseline ASPECTS on NCCT and CTASI. Of note, the discriminative ability of the baseline NIHSS score was higher compared to all baseline imaging scores which is in line with previous data published by our group [7] .
Time from symptom onset was the only additional independent predictor of functional outcome among patients in whom recanalization was achieved in the study by Rosenthal et al. [23] . In line with these results, 1 patient in our study achieved an independent functional outcome despite a low combined score. This patient was treated ultra early, i.e. within 90 min from symptom onset. The information derived from CTASI may vary. In early time windows, CTASI may represent something akin to time-to-peak maps with potentially reversible hypoattenuation with recanalization [12] . In later time windows, CTASI may behave more like a cerebral blood volume parameter map which is highly predictive of the final infarct volume [22] .
We have recently shown that the intracranial thrombus extent, assessed with a novel CBS applied on CTA, predicts functional outcome in patients with acute cerebral ischemia [20] . Adopting the same score, Tan et al. [24] have demonstrated lower recanalization rates in patients with low CBSs (i.e. large thrombus burden) compared to patients with high CBSs (i.e. small thrombus burden). As recanalization is unlikely in patients with high thrombus burden, the combined assessment of hypoattenuation on CTASI (CTASI-ASPECTS) and intracranial thrombus burden on CTA (CBS) may identify patients who have a poor functional outcome despite early IV thrombolysis. Such patients may have similar characteristics as patients with an MRI-based malignant profile in the DEFUSE study and the EPITHET trial [2, 3] . Comparison of multimodal stroke MRI and CTA in predicting functional outcome may be possible in ongoing trials like the Efficacy and Safety Study of Desmoteplase to treat Acute Ischemic Stroke (DIAS-3) [25] . Moreover, such patients may benefit from early aggressive treatment paradigms like immediate combined IV-IA therapy as currently tested in the Interventional Management of Stroke 3 (IMS-3) trial [26] . A low combined CTASI-AS-PECTS + CBS score was associated with poor functional outcome regardless of the treatment modality (IV thrombolysis vs. combined IV-IA therapy) in our study, although the small size of the study hinders definitive conclusions.
Our study is limited by the retrospective study design and monocentric data analysis. Moreover, as not all acute stroke patients in our center received CTA before thrombolytic therapy, results of our study may have been influenced by selection bias. The relatively large number of patients who have evidence of an intracranial arterial occlusion on CTA may point to this limitation (i.e. selection bias). However, the median NIHSS score in our study (14) is similar to the median NIHSS scores of patients in the pooled analysis of randomized controlled thrombolysis trials and patients in the SITS-MOST registry, suggesting that patients in our study represent an average IV rtPAtreated stroke population [27, 28] . Due to the retrospective study design we do not have recanalization data and also did not systematically collect information regarding hyperdense MCA signs which have been shown to predict outcome in large rtPA registries [29] . The poor functional outcome of patients with a low combined score may have partially been due to a self-fulfilling prophecy as physicians may have limited patient care in early treat-ment phases due to expectation of a poor functional outcome [30, 31] . We included patients who received additional IA therapies after initiation of IV thrombolysis. However, the decision to treat with additional IA therapies was not influenced by the combined CTASI-AS-PECTS and CBS score. Moreover, the functional outcome in patients with low combined scores was poor in all but 1 patient regardless of the treatment modality in our study.
In summary, patients with a low combined CTASI-ASPECTS plus CBS score are unlikely to achieve an independent functional outcome despite IV thrombolysis or combined IV-IA therapy initiated within 3 h from symptom onset. It needs to be determined which of these patients benefit from IV thrombolysis, which may be actually harmed with IV thrombolysis and which may benefit from more aggressive treatment paradigms like immediate combined IV-IA therapy. Ongoing studies like the IMS-3 trial may help to answer this question [26] . We suspect that the answer to this question will vary by stroke onset-to-treatment time.
